ARBUCKLE STUART A (EVP\Chief Commercial Officer) reported 1 transaction at VERTEX PHARMACEUTICALS INC / MA
Review the transaction codes below to understand the nature of each event.
Filed: 2/28/2025ACC: 0000875320-25-000124
Officer· EVP\Chief Commercial Officer
Since Jun 2018
-7.07K
Net shares
Net seller
$3.39M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.07K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.07K
Price / share
$479.61
Trade value
$3.39M
% of position
10.1%
2/26/2025
70.01K→62.94K
Total
Net shares
−7.07K
Net value
-$3.39M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2025 | F · Tax Withholding | −7.07K | $479.61 | $3.39M | 10.1% | 70.01K | 62.94K |
| Total | −7.07K | -$3.39M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned140.00
Total
140.00 indirect140.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 140.00 | Indirect |
| Total | 140.00 | 140.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported